A Sequel to Sanger: Amplicon Sequencing That Scales
Authors:
- Paul Dn HebertPHPaul Dn Hebert
- Thomas Wa BraukmannTBThomas Wa Braukmann
- Sean Wj ProsserSPSean Wj Prosser
- Sujeevan RatnasinghamSRSujeevan Ratnasingham
- Jeremy R DewaardJDJeremy R Dewaard
- Natalia V IvanovaNINatalia V Ivanova
- Daniel H JanzenDJDaniel H Janzen
- Winnie HallwachsWHWinnie Hallwachs
- Suresh NaikSNSuresh Naik
- Jayme E SonesJSJayme E Sones
- Evgeny V ZakharovEZEvgeny V Zakharov
Preprint
Abstract
Although high-throughput sequencers (HTS) have largely displaced their Sanger counterparts, the short read lengths and high error rates of most platforms constrain their utility for amplicon sequencing. The present study tests the capacity of single molecule, real-time (SMRT) sequencing implemented on the SEQUEL platform to overcome these limitations, employing 658 bp amplicons of the mitochondrial cytochrome c oxidase I gene as a model system. By examining templates from more than 5,000 species and 20,000 specimens, the performance of SMRT sequencing was tested with amplicons showing wide variation in GC composition and varied sequence attributes. SMRT and Sanger sequences were very similar, but SMRT sequencing provided more complete coverage, especially for amplicons with homopolymer tracts. Because it can characterize amplicon pools from 10,000 DNA extracts in a single run, the SEQUEL reduces costs 40-fold from Sanger analysis. Reflecting the capacity of each instrument to recover sequences from more than five million DNA extracts a year, this platform facilitates massive amplicon characterization.Keywords
All Related Versions
- Published version: BMC Genomics, 19 (1), 219.
This publication has 45 references indexed in Scilit:
- Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel TestingThe Journal of Molecular Diagnostics, 2016
- Counting animal species with DNA barcodes: Canadian insectsPhilosophical Transactions of the Royal Society B: Biological Sciences, 2016
- Contiguous and accuratede novoassembly of metazoan genomes with modest long read coverageNucleic Acids Research, 2016
- Long-read sequencing and de novo assembly of a Chinese genomeNature Communications, 2016
- Confirming Variants in Next-Generation Sequencing Panel Testing by Sanger SequencingThe Journal of Molecular Diagnostics, 2015
- Massively parallel multiplex DNA sequencing for specimen identification using an Illumina MiSeq platformScientific Reports, 2015
- Translating Sanger-Based Routine DNA Diagnostics into Generic Massive Parallel Ion Semiconductor SequencingClinical Chemistry, 2015
- ‘Big data’, Hadoop and cloud computing in genomicsJournal of Biomedical Informatics, 2013
- A tale of three next generation sequencing platforms: comparison of Ion torrent, pacific biosciences and illumina MiSeq sequencersBMC Genomics, 2012
- A decade’s perspective on DNA sequencing technologyNature, 2011